CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
102 hedge funds and large institutions have $88.7M invested in Cymabay Therapeutics in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
36% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 25
Holders
102
Holding in Top 10
2
Calls
$955K
Puts
–
Top Buyers
| 1 | +$3.85M | |
| 2 | +$3.5M | |
| 3 | +$2.24M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$1.59M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.13M |
Top Sellers
| 1 | -$4.54M | |
| 2 | -$3.37M | |
| 3 | -$2.95M | |
| 4 |
Millennium Management
New York
|
-$2.13M |
| 5 |
Renaissance Technologies
New York
|
-$833K |